ERBB2 and neoplasm: However, there were no significant difference in Ki67 staining between RM11A+Dox tumor cells (Figure 4c) and RM11A+Dox/ErbB2 tumor cells 14 d post injection (Figure 4d), suggesting that ErbB2 increases tumor growth rate during the first few days of tumor development but not once tumors have been established.